MAJIC: A phase 3 prospective, multicenter, randomized, open-label trial of acalabrutinib plus venetoclax versus venetoclax plus obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma Meeting Abstract
| Authors: | Davids, M. S.; Mato, A. R.; Hum, J.; Wargo, S.; Emeribe, U.; Shahkarami, M.; Sokolowski, K.; Biondo, J. M. L.; Abhyankar, S.; Hermann, R.; Sharman, J. P. |
| Abstract Title: | MAJIC: A phase 3 prospective, multicenter, randomized, open-label trial of acalabrutinib plus venetoclax versus venetoclax plus obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma |
| Meeting Title: | 63nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736398806023 |
| DOI: | 10.1182/blood-2021-148155 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1553 -- Hybrid meeting, also took place online -- Source: Wos |
